APA (7th ed.) Citation

F, L., Y, P., H, Q., MC, X., CH, D., X, Z., & WF, X. (2024). Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α)-induced differentiation therapy for hepatocellular carcinoma. Journal of digestive diseases, 25(4), 255. https://doi.org/10.1111/1751-2980.13272

Chicago Style (17th ed.) Citation

F, Liu, Peng Y, Qian H, Xiao MC, Ding CH, Zhang X, and Xie WF. "Abrogating K458 Acetylation Enhances Hepatocyte Nuclear Factor 4α (HNF4α)-induced Differentiation Therapy for Hepatocellular Carcinoma." Journal of Digestive Diseases 25, no. 4 (2024): 255. https://doi.org/10.1111/1751-2980.13272.

MLA (9th ed.) Citation

F, Liu, et al. "Abrogating K458 Acetylation Enhances Hepatocyte Nuclear Factor 4α (HNF4α)-induced Differentiation Therapy for Hepatocellular Carcinoma." Journal of Digestive Diseases, vol. 25, no. 4, 2024, p. 255, https://doi.org/10.1111/1751-2980.13272.